Zachariah Lockhart

Zachariah Lockhart is a Senior Scientist I in Medicinal Chemistry at MSD in the UK, focusing on designing and synthesizing molecules to address neurodegeneration through the application of organic chemistry and interdisciplinary collaboration. Previous experience includes a role as a Research Assistant at Queen's University Belfast, where Zachariah contributed to the development of unnatural oligomeric molecules to disrupt protein–protein interactions, and an Industrial Placement at AstraZeneca, optimizing drug manufacturing processes for chronic obstructive pulmonary disorder and blood cancer treatments. Zachariah's academic background includes a DPhil in Synthesis for Biology and Medicine from the University of Oxford and an MSci in Chemistry with Professional Studies from Queen's University Belfast.